Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

Indiana University

Status: Completed

Conditions: Triple Negative Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05730010

CTO-IUSCCC-0803

Details and patient eligibility

About

This study will examine how ctDNA and additional prognostic genomic information in patients with early stage breast cancer might influences patient decision- making regarding systemic therapy options.

Full description

This study is an electronically delivered, one time cross sectional survey study. The investigators want to understand how patients with triple negative breast cancer at high risk for disease recurrence will prioritize additional benefit over toxicity when considering treatment options, and if their knowledge of ctDNA positivity versus negativity will further shift this balance toward benefit.

Enrollment: 289 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Self- reported history of non-metastatic breast cancer
• Self- reported history of receiving chemotherapy for breast cancer
• Self- reported history of chemotherapy completed at least 6 months ago but no more than 10 years ago
• Able to complete an online survey
• English speaking

Exclusion criteria

N/A